热门资讯> 正文
Sanara MedTech每股收益为-0.21美元,收入为1,850万美元,相差0.70万美元
2024-05-14 23:22
- Sanara MedTech press release (NASDAQ:SMTI): Q1 EPS of -$0.21.
- Revenue of $18.5M misses by $0.7M.
More on Sanara MedTech
- Sanara MedTech Inc. (SMTI) Q4 2023 Earnings Call Transcript
- Sanara MedTech Inc. 2023 Q4 - Results - Earnings Call Presentation
- Sanara MedTech appoints Jake Waldrop as COO and Tyler Palmer as Chief Corporate Development and Strategy Officer
- Seeking Alpha’s Quant Rating on Sanara MedTech
- Historical earnings data for Sanara MedTech
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。